论文部分内容阅读
2005年6月21日,来自8个不同国家的21位科学家在法国里昂的国际癌症研究机构(International Agency forResearch on Cancer,IARC)召开会议,对复合雌-孕激素避孕药(复合激素避孕药)和激素替代疗法的致癌性进行评估。评估结果将报道在IARC专论的第91卷上[1],并对以前关于这些药品
On June 21, 2005, 21 scientists from eight different countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to screen for combined estrogen-progestogen contraceptives (corticosteroids) And carcinogenicity of hormone replacement therapy. The results of the assessment will be reported on Volume 91 of the IARC monograph [1], and the previous studies on these drugs